Novartis Bioventures Ltd Adhera Therapeutics, Inc. (ATRX) insider trading activity
Novartis Bioventures LTD is > 10% Shareholder of Adhera Therapeutics, Inc.. Currently has a direct ownership of 2.5 Million shares of ATRX, which is worth approximately $0. The most recent transaction as insider was on Jan 26, 2011, when has been sold 74,500 shares (Common Stock) at a price of $1.15 per share, resulting in proceeds of $85,675. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.5M
0%
3M change
0%
12M change
Total Value Held
$0
Novartis Bioventures Ltd Transaction History
Also insider at
NBL
Novartis Bioventures LTD
> 10% Shareholder
Basel, V8